However, the cardioprotective effect of rosuvastatin was abrogated with NLRP3-miRNA treatment, confirming that rosuvastatin alleviated cardiac dysfunction in DCM rats via suppressing NLRP3 inflammasome [33]. The gene discussed is NLRP3; the disease is familial dilated cardiomyopathy.